| Literature DB >> 1779263 |
G Spinelli1, N Bardazzi, A Citernesi, M Fontanarosa, P Curiel.
Abstract
Tamoxifen is an important agent for the treatment of breast cancer. Occasionally the drug, which is an antiestrogen, has agonistic estrogenic activity. The authors describe three new cases of endometrial carcinoma developing in breast cancer patients taking tamoxifen and stress the necessity of carefully monitoring the uterine cavity under tamoxifen treatment.Entities:
Mesh：
Substances：
Year: 1991 PMID： 1779263 DOI： 10.1080/1120009x.1991.11739104
Source DB: PubMed Journal: J Chemother ISSN： 1120-009X Impact factor: 1.714